Alan Cantor

Active 1984–2023

105
Papers
18,944
Citations
81
h-index
105
i10-index

Citations

Citations per year for Alan Cantor1986: 1 citations1987: 4 citations1988: 7 citations1989: 6 citations1990: 12 citations1991: 4 citations1992: 3 citations1993: 10 citations1994: 11 citations1995: 16 citations1996: 20 citations1997: 28 citations1998: 17 citations1999: 36 citations2000: 55 citations2001: 50 citations2002: 94 citations2003: 150 citations2004: 173 citations2005: 213 citations2006: 222 citations2007: 232 citations2008: 225 citations2009: 241 citations2010: 244 citations2011: 271 citations2012: 217 citations2013: 223 citations2014: 190 citations2015: 185 citations2016: 159 citations2017: 145 citations2018: 139 citations2019: 365 citations2020: 392 citations2021: 383 citations2022: 283 citations2023: 196 citations2024: 289 citations2025: 91 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,827 citing papers, 35.6% of this breakdownUnited Kingdom: 560 citing papers, 7.1% of this breakdownChina: 541 citing papers, 6.8% of this breakdownGermany: 350 citing papers, 4.4% of this breakdownCanada: 349 citing papers, 4.4% of this breakdownJapan: 297 citing papers, 3.7% of this breakdownItaly: 288 citing papers, 3.6% of this breakdownFrance: 274 citing papers, 3.5% of this breakdownAustralia: 246 citing papers, 3.1% of this breakdownNetherlands: 220 citing papers, 2.8% of this breakdownSpain: 170 citing papers, 2.1% of this breakdownSwitzerland: 146 citing papers, 1.8% of this breakdown
0%35.6%Other 21.1%

Fields

  • Medicine50.5%
  • Biochemistry, Genetics and Molecular Biology33.4%
  • Immunology and Microbiology5.3%
  • Neuroscience2.9%
  • Nursing1.9%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Other4.8%

Topics

  • Epigenetics and DNA Methylation3%
  • Cytokine Signaling Pathways and Interactions2%
  • Neuroblastoma Research and Treatments1.8%
  • RNA modifications and cancer1.8%
  • Genomics and Chromatin Dynamics1.7%
  • Hemoglobinopathies and Related Disorders1.7%
  • Other88%

Coauthors

All papers

Open in search
  1. Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

    Authors: , , , , , , , , , - Science 2008 cited by 911

  2. A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses

    Authors: , , , , , , , , , , , , , , , , - Molecular Therapy 2014 cited by 322

  3. Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo

    Authors: , , , , , , - The Journal of Experimental Medicine 2002 cited by 598

  4. A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs

    Authors: , , , , , , , - Cell 2010 cited by 675

  5. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects

    Authors: , , , - Brain Research Bulletin 2001 cited by 281

  6. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslová, Hugh Young Rienhoff, Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Deolinda Rodrigues Pereira Velloso, Benedict Yan, Erika Kim, Raman Sood, Amy P. Hsu, Steven M. Holland, Kerry Phillips, Nicola Poplawski, Milena Babic, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Ian D. Lewis, Julian Cooney, Rachel Susman, Lucy C. Fox, Piers Blombery, Deepak Singhal, Devendra Hiwase, Belinda Phipson, Andreas Schreiber, Christopher N Hahn, Hamish S. Scott, Paul Liu, Lucy A. Godley, Anna Brown - Blood Advances 2023 cited by 39

  7. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

    Authors: , , , , , , , , , , , , , - Cancer 2005 cited by 691

  8. A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study

    Authors: , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2020 cited by 82

  9. Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection

    Authors: , , , , , , , , - International Journal of Cancer 2002 cited by 363

  10. Lysophospholipids Are Potential Biomarkers of Ovarian Cancer

    Authors: , , , , , , , , , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2004 cited by 337

  11. Prediction of Radiation Sensitivity Using a Gene Expression Classifier

    Authors: , , , , , , , , , , , - Cancer Research 2005 cited by 223

  12. Sample-size calculations for Cohen's kappa.

    Authors: - Psychological Methods 1996 cited by 205

  13. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

    Authors: , , , , , , , , , , , , , , - 2002 cited by 536

  14. Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen J. Chanock, Richard A. Young, Leonard I. Zon - Nature Genetics 2020 cited by 49

  15. GATA-1 Converts Lymphoid and Myelomonocytic Progenitors into the Megakaryocyte/Erythrocyte Lineages

    Authors: , , , , , - Immunity 2003 cited by 198

  16. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study

    Authors: , , , , , , , , , , , , , , - Neuro-Oncology 2014 cited by 147

  17. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffery B. Allen, Alyssa Reddy, Robert A. Avery, Cynthia Flanigan - Neurology 2016 cited by 104

  18. Pilot Randomized Controlled Trial of a Home Vegetable Gardening Intervention among Older Cancer Survivors Shows Feasibility, Satisfaction, and Promise in Improving Vegetable and Fruit Consumption, Reassurance of Worth, and the Trajectory of Central Adiposity

    Authors: , , , , , , , , , , - Journal of the Academy of Nutrition and Dietetics 2018 cited by 76

  19. TIF1γ Controls Erythroid Cell Fate by Regulating Transcription Elongation

    Authors: , , , , , , , , , , , , , , , - Cell 2010 cited by 210

  20. Tumor Biology of Infiltrating Lobular Carcinoma

    Authors: , , , , , , , , - Annals of Surgery 1995 cited by 166

  21. A home‐based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors

    Authors: , , , , , , , , - Cancer 2018 cited by 78

  22. TMEM14C is required for erythroid mitochondrial heme metabolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diane M. Ward, Harry A. Dailey, John D. Phillips, Luanne L. Peters, Barry H. Paw - Journal of Clinical Investigation 2014 cited by 75

  23. Transcriptional regulation of erythropoiesis: an affair involving multiple partners

    Authors: , - Oncogene 2002 cited by 587

  24. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

    Authors: , , , , , - 2003 cited by 569